{"id":2914,"date":"2019-05-02T06:30:00","date_gmt":"2019-05-02T06:30:00","guid":{"rendered":"https:\/\/www.xvivogroup.com\/us\/mfn_news\/xvivos-patents-for-the-heart-preservation-fluid-approved-in-the-us-and-europe\/"},"modified":"2019-05-02T06:30:00","modified_gmt":"2019-05-02T06:30:00","slug":"xvivos-patents-for-the-heart-preservation-fluid-approved-in-the-us-and-europe","status":"publish","type":"mfn_news","link":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/xvivos-patents-for-the-heart-preservation-fluid-approved-in-the-us-and-europe\/","title":{"rendered":"XVIVO\u2019s patents for the heart preservation fluid approved in the US and Europe"},"content":{"rendered":"<div class=\"mfn-preamble\"><strong>XVIVO\u2019s patent for the heart preservation fluid has been approved in the US and Europe. Canada has already approved this patent. XVIVO has also previously received a patent for the heart evaluation equipment in Europe, Australia, Canada and China. The review of the patent application for the heart evaluation equipment is in its final stages in the US. Together these patents strengthen XVIVO\u2019s position in the heart transplantation field on all major markets in the world.<\/strong><\/div>\n<p><span>XVIVO has two main patents in the field of heart transplantation. The first of these covers the preservation fluid that is used in heart preservation and the other covers important parts of the evaluation equipment that is to be used for heart evaluation after preservation, but before transplantation. Patent applications have been submitted from both of these patent families recently. <\/span><\/p>\n<p><span>These patents strengthens XVIVO\u00b4s position in the field of heart transplantation. Patents are important in XVIVO\u2019s research-intensive business areas and not only entail a temporary monopoly situation for XVIVO\u2019s products, but can also be important in discussions with potential collaboration partners and to give XVIVO freedom in its further research and product development.<\/span><\/p>\n<p><span>\u201cIt is positive that these patents have been approved on important markets in the world. This means that the company will continue to invest in products for both preservation and evaluation of the heart with even greater confidence,\u201d says Magnus Nilsson, CEO of XVIVO Perfusion.<\/span><\/p>\n<p><span>May 2, 2019<br \/><\/span>Gothenburg<br \/>XVIVO Perfusion AB (publ)<br \/>Magnus Nilsson, CEO\u00a0<\/p>\n<div class=\"mfn-footer\">\n<p><span>For further information please contact:<\/span><\/p>\n<p><span>Christoffer Rosenblad, CFO, +46 735 192159, christoffer.rosenblad@xvivoperfusion.com<br \/>Magnus Nilsson, CEO, +46 31 788 2150, magnus.nilsson@xvivoperfusion.com<\/span><br \/><span>For further information on XVIVO Perfusion\u2019s business, please refer to the company\u2019s website, www.xvivoperfusion.com<\/span><\/p>\n<p><span>This information is information that Xvivo Perfusion AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation.\u00a0\u00a0The information was submitted for publication, through the agency of the contact person set out above, at 08:30 am CET on May 2, 2019.<\/span><\/p>\n<p><span>This is a translation of the Swedish version of the press release. When in doubt, the Swedish wording prevails.<\/span><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>XVIVO\u2019s patent for the heart preservation fluid has been approved in the US and Europe. Canada has already approved this&#8230;<\/p>\n","protected":false},"template":"","class_list":["post-2914","mfn_news","type-mfn_news","status-publish","hentry","mfn-news-tag-mfn-ci-other","mfn-news-tag-mfn","mfn-news-tag-mfn-type-ir","mfn-news-tag-mfn-lang-en","mfn-news-tag-mfn-regulatory","mfn-news-tag-mfn-regulatory-mar","mfn-news-tag-mfn-ci"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>XVIVO\u2019s patents for the heart preservation fluid approved in the US and Europe - XVIVO<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.xvivogroup.com\/us\/pressreleases\/xvivos-patents-for-the-heart-preservation-fluid-approved-in-the-us-and-europe\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"XVIVO\u2019s patents for the heart preservation fluid approved in the US and Europe - XVIVO\" \/>\n<meta property=\"og:description\" content=\"XVIVO\u2019s patent for the heart preservation fluid has been approved in the US and Europe. Canada has already approved this...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.xvivogroup.com\/us\/pressreleases\/xvivos-patents-for-the-heart-preservation-fluid-approved-in-the-us-and-europe\/\" \/>\n<meta property=\"og:site_name\" content=\"United States\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/xvivos-patents-for-the-heart-preservation-fluid-approved-in-the-us-and-europe\\\/\",\"url\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/xvivos-patents-for-the-heart-preservation-fluid-approved-in-the-us-and-europe\\\/\",\"name\":\"XVIVO\u2019s patents for the heart preservation fluid approved in the US and Europe - XVIVO\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/#website\"},\"datePublished\":\"2019-05-02T06:30:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/xvivos-patents-for-the-heart-preservation-fluid-approved-in-the-us-and-europe\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/xvivos-patents-for-the-heart-preservation-fluid-approved-in-the-us-and-europe\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/xvivos-patents-for-the-heart-preservation-fluid-approved-in-the-us-and-europe\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"XVIVO\u2019s patents for the heart preservation fluid approved in the US and Europe\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/#website\",\"url\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/\",\"name\":\"United States\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"XVIVO\u2019s patents for the heart preservation fluid approved in the US and Europe - XVIVO","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/xvivos-patents-for-the-heart-preservation-fluid-approved-in-the-us-and-europe\/","og_locale":"en_US","og_type":"article","og_title":"XVIVO\u2019s patents for the heart preservation fluid approved in the US and Europe - XVIVO","og_description":"XVIVO\u2019s patent for the heart preservation fluid has been approved in the US and Europe. Canada has already approved this...","og_url":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/xvivos-patents-for-the-heart-preservation-fluid-approved-in-the-us-and-europe\/","og_site_name":"United States","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/xvivos-patents-for-the-heart-preservation-fluid-approved-in-the-us-and-europe\/","url":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/xvivos-patents-for-the-heart-preservation-fluid-approved-in-the-us-and-europe\/","name":"XVIVO\u2019s patents for the heart preservation fluid approved in the US and Europe - XVIVO","isPartOf":{"@id":"https:\/\/www.xvivogroup.com\/us\/#website"},"datePublished":"2019-05-02T06:30:00+00:00","breadcrumb":{"@id":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/xvivos-patents-for-the-heart-preservation-fluid-approved-in-the-us-and-europe\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.xvivogroup.com\/us\/pressreleases\/xvivos-patents-for-the-heart-preservation-fluid-approved-in-the-us-and-europe\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/xvivos-patents-for-the-heart-preservation-fluid-approved-in-the-us-and-europe\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.xvivogroup.com\/us\/"},{"@type":"ListItem","position":2,"name":"XVIVO\u2019s patents for the heart preservation fluid approved in the US and Europe"}]},{"@type":"WebSite","@id":"https:\/\/www.xvivogroup.com\/us\/#website","url":"https:\/\/www.xvivogroup.com\/us\/","name":"United States","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.xvivogroup.com\/us\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/www.xvivogroup.com\/us\/wp-json\/wp\/v2\/mfn_news\/2914","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.xvivogroup.com\/us\/wp-json\/wp\/v2\/mfn_news"}],"about":[{"href":"https:\/\/www.xvivogroup.com\/us\/wp-json\/wp\/v2\/types\/mfn_news"}],"wp:attachment":[{"href":"https:\/\/www.xvivogroup.com\/us\/wp-json\/wp\/v2\/media?parent=2914"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}